4-Methylmorpholine → (S)-tert-butyl (3-cyclopentyl-1-(methoxy(methyl)amino)-1-oxopropan-2-yl)carbamate

HRID 58840Notes

Reaction equation

HRID 58840 reaction equation
[C:1]([O:5][C:6]([NH:8][C@@H:9]([CH2:13][CH:14]1[CH2:18][CH2:17][CH2:16][CH2:15]1)[C:10]([OH:12])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].ClC(OCC)=O.CN1CCOCC1.Cl.[CH3:33][NH:34][O:35][CH3:36]>C(Cl)Cl.C1COCC1.C(Cl)Cl>[CH:14]1([CH2:13][C@H:9]([NH:8][C:6](=[O:7])[O:5][C:1]([CH3:2])([CH3:3])[CH3:4])[C:10]([N:34]([O:35][CH3:36])[CH3:33])=[O:12])[CH2:18][CH2:17][CH2:16][CH2:15]1

Participants

7

Conditions

Temperature
0 °C

Procedure

To a flask charged with compound (S)-2-((tert-butoxycarbonyl)amino)-3-cyclopentylpropanoic acid (55.0 g, 214 mmol) was added THF/DCM (800 mL, 1:1). The solution was cooled to 0° C. and ethyl chloroformate (24.5 mL, 257 mmol) and NMM (28.4 mL, 257 mmol) was added dropwise sequentially. After addition, the mixture was stirred at 0° C. under nitrogen for 1 h. To the other flask charged with N,O-dimethylhydroxylamine HCl (25.0 g, 257 mmol) was added DCM (400 mL). The mixture was cooled to 0° C. and TEA (38.7 mL, 278 mmol) was added. The resulting mixture was transferred into the former reaction flask. The reaction mixture was allowed to warm to ambient temperature and stirred overnight. The reaction was then quenched with water (500 mL) and the two phases were separated. The organic phase was washed with water (500 mL), dried over anhydrous sodium sulfate, and concentrated to afford (S)-tert-butyl (3-cyclopentyl-1-(methoxy(methyl)amino)-1-oxopropan-2-yl)carbamate as colorless oil (60 g, 93% yield), which was used in the next step without further purification.

Workup

  1. additionAfter addition
  2. temperatureThe mixture was cooled to 0° C.
  3. temperatureto warm to ambient temperature
  4. stirringstirred overnight
  5. customThe reaction was then quenched with water (500 mL)
  6. customthe two phases were separated
  7. washThe organic phase was washed with water (500 mL)
  8. dry with materialdried over anhydrous sodium sulfate
  9. concentrationconcentrated

Sources & evidence

ORD record
ord-b3797f63a9394f6da1e13b3e6a8793f8
Source dataset
uspto-grants-2016_09
Patent number
US09434761B2

Reaction notes

Loading…